LNAI
LUNAI BIOWORKS INC.
Company Overview
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
SectorHealthcare
IndustryBiotechnology
Market Cap$1.3M
Last DividendNone
Employees12
CEODavid H. Weinstein
Valuation
Current Price$0.29
Fair Value?$000.00
Valuation?No valuation
Current PE ?N/Aⓘ
Hist. PE ?N/Aⓘ
EPS (TTM) ?-0.77
Forward EPS Growth ?—
Historical Growth ?62.86%
Equity, FCF, Long Term Debt, Net Profit, and Shares Outstanding history charts are available on the Pro plan for just $9.99/month.Sign in to unlock Pro
Price?
EPS?
Revenue?
Equity?
ProAvailable on the Pro plan
Free Cash Flow?
ProAvailable on the Pro plan
Long Term Debt?
ProAvailable on the Pro plan
Net Profit?
ProAvailable on the Pro plan
Shares Outstanding?
ProAvailable on the Pro plan
Last updated: 10/23/2026, 11:26:33 PM